These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

112 related articles for article (PubMed ID: 17556060)

  • 1. Relevance of H1-receptor occupancy to H1-antihistamine dosing in children.
    Simons KJ; Benedetti MS; Simons FE; Gillard M; Baltes E
    J Allergy Clin Immunol; 2007 Jun; 119(6):1551-4. PubMed ID: 17556060
    [No Abstract]   [Full Text] [Related]  

  • 2. Peripheral and central H1 histamine receptor occupancy by levocetirizine, a non-sedating antihistamine; a time course study in the guinea pig.
    Gupta A; Gillard M; Christophe B; Chatelain P; Massingham R; Hammarlund-Udenaes M
    Br J Pharmacol; 2007 Aug; 151(7):1129-36. PubMed ID: 17558437
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Brain histamine H1 receptor occupancy measured by PET after oral administration of levocetirizine, a non-sedating antihistamine.
    Hiraoka K; Tashiro M; Grobosch T; Maurer M; Oda K; Toyohara J; Ishii K; Ishiwata K; Yanai K
    Expert Opin Drug Saf; 2015 Feb; 14(2):199-206. PubMed ID: 25466429
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Dose dependency of brain histamine H(1) receptor occupancy following oral administration of cetirizine hydrochloride measured using PET with [11C]doxepin.
    Tashiro M; Kato M; Miyake M; Watanuki S; Funaki Y; Ishikawa Y; Iwata R; Yanai K
    Hum Psychopharmacol; 2009 Oct; 24(7):540-8. PubMed ID: 19697300
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Efficacy and safety of bilastine 20 mg compared with cetirizine 10 mg and placebo for the symptomatic treatment of seasonal allergic rhinitis: a randomized, double-blind, parallel-group study.
    Kuna P; Bachert C; Nowacki Z; van Cauwenberge P; Agache I; Fouquert L; Roger A; Sologuren A; Valiente R;
    Clin Exp Allergy; 2009 Sep; 39(9):1338-47. PubMed ID: 19438584
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Increasing the dose of cetirizine may lead to better control of chronic idiopathic urticaria: an open study of 21 patients.
    Kameyoshi Y; Tanaka T; Mihara S; Takahagi S; Niimi N; Hide M
    Br J Dermatol; 2007 Oct; 157(4):803-4. PubMed ID: 17627798
    [No Abstract]   [Full Text] [Related]  

  • 7. Bacillus clausii effects in children with allergic rhinitis.
    Ciprandi G; Vizzaccaro A; Cirillo I; Tosca MA
    Allergy; 2005 May; 60(5):702-3. PubMed ID: 15813820
    [No Abstract]   [Full Text] [Related]  

  • 8. A review of the role of levocetirizine as an effective therapy for allergic disease.
    Walsh GM
    Expert Opin Pharmacother; 2008 Apr; 9(5):859-67. PubMed ID: 18345961
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Chronic urticaria: clinical aspects and focus on a new antihistamine, levocetirizine.
    Kapp A; Wedi B
    J Drugs Dermatol; 2004; 3(6):632-9. PubMed ID: 15624746
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The histamine H(1)-receptor antagonist cetirizine does not interact with bradykinin B(1) or B(2)-receptors in vitro.
    Christophe B; Maleux MR; Gillard M; Chatelain P; Peck MJ; Massingham R
    Inflamm Res; 2004 Mar; 53 Suppl 1():S81-2. PubMed ID: 15054630
    [No Abstract]   [Full Text] [Related]  

  • 11. Levocetirizine: pharmacokinetics and pharmacodynamics in children age 6 to 11 years.
    Simons FE; Simons KJ
    J Allergy Clin Immunol; 2005 Aug; 116(2):355-61. PubMed ID: 16083790
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Fixed drug eruption due to levocetirizine.
    Guptha SD; Prabhakar SM; Sacchidanand S
    Indian J Dermatol Venereol Leprol; 2005; 71(5):361-2. PubMed ID: 16394467
    [No Abstract]   [Full Text] [Related]  

  • 13. Idiopathic bullous eosinophilic cellulitis (Wells syndrome) responsive to topical tacrolimus and antihistamine combination.
    Verma P; Singal A; Sharma S
    Indian J Dermatol Venereol Leprol; 2012; 78(3):378-80. PubMed ID: 22565446
    [No Abstract]   [Full Text] [Related]  

  • 14. Cetirizine from topical phosphatidylcholine-hydrogenated liposomes: evaluation of peripheral antihistaminic activity and systemic absorption in a rabbit model.
    Elzainy AA; Gu X; Simons FE; Simons KJ
    AAPS J; 2004 Aug; 6(3):e18. PubMed ID: 15760103
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Combined mediator antagonism for allergic rhinitis.
    Jackson CM; Lipworth BJ
    Allergy; 2004 Mar; 59(3):276-9. PubMed ID: 14982508
    [No Abstract]   [Full Text] [Related]  

  • 16. Chronic unremitting urticaria: is the use of antihistamines above the licensed dose effective? A preliminary study of cetirizine at licensed and above-licensed doses.
    Asero R
    Clin Exp Dermatol; 2007 Jan; 32(1):34-8. PubMed ID: 17042777
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Levocetirizine in the treatment of allergic diseases.
    Scordamaglia F; Compalati E; Baiardini I; Scordamaglia A; Canonica GW
    Expert Opin Pharmacother; 2009 Oct; 10(14):2367-77. PubMed ID: 19663743
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Cetirizine, a histamine H1 receptor antagonist, decreases the first stage of orthodontic tooth movement in rats.
    Kriznar I; Sprogar S; Drevensek M; Vaupotic T; Drevensek G
    Inflamm Res; 2008; 57 Suppl 1():S29-30. PubMed ID: 18345503
    [No Abstract]   [Full Text] [Related]  

  • 19. Cerebral histamine H1 receptor binding potential measured with PET under a test dose of olopatadine, an antihistamine, is reduced after repeated administration of olopatadine.
    Senda M; Kubo N; Adachi K; Ikari Y; Matsumoto K; Shimizu K; Tominaga H
    J Nucl Med; 2009 Jun; 50(6):887-92. PubMed ID: 19443589
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Circadian rhythms in the toxic effects of the histamine antagonist cetirizine in mice].
    Dridi D; Ben Attia M; Reinberg A; Boughattas NA
    Pathol Biol (Paris); 2005 May; 53(4):193-8. PubMed ID: 15850951
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.